Mesco Pharmaceuticals Limited, a active public limited company, was established on 12 August 1986 in Nanital, Uttarakhand, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: L24111UR1986PLC015895. Registered under ROC Roc Uttarakhand. it is listed on BSE: 500274. It has an authorized capital of ₹30.00 Cr and a paid-up capital of ₹19.74 Cr.
It upholds a compliant status. Its leadership includes Dhruv Dushyant Kumar Singh (Director), Hawa Singh Chahar (Director), Rajesh Tibrewal (Additional Director). Past directors included Nurani Shankar Parameswaran, Dushyant Kumar Singh, Vijaya Batth. It holds no open charges and ₹10.00 Cr settled loans. Its latest AGM occurred on 29 September 2021, with the balance sheet filed on 31 March 2021. It is based at Upper Kesalton Tallital Nanital, Nanital, Uttarakhand, 263001.
L24111UR1986PLC015895
015895
12 August 1986
₹30.00 Cr
₹19.74 Cr
Roc Uttarakhand
Listed (BSE: 500274)
Active
Explore comprehensive insights into Mesco Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Dhruv Dushyant Kumar Singh | Director | 31 Jul 2020 | Current |
| Hawa Singh Chahar | Director | 21 Jun 2019 | Current |
| Rajesh Tibrewal | Additional Director | 18 Nov 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 30 Sep 2015 | Past |
| Pramod Abcsdd | Director | 28 Sep 2020 | Past |
| Pramod Abcsdd | Additional Director | 02 Jul 2016 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2016 | Past |
| Pramod Abcsdd | Director | 19 Feb 2021 | Past |
| Pramod Abcsdd | Director | 31 Jul 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Mesco Pharmaceuticals Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 95.93% increase in profit. The company's net worth dipped by a decrease of 0.04%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Mesco Pharmaceuticals had a promoter holding of 39.30% and a public holding of 60.70%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹100,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Mar 1995 | The Industrial Finance Corporation Of India | ₹10.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Mesco Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Mesco Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mesco Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Rajesh Tibrewal was appointed as a Additional Director was appointed as a Additional Director on 18 Nov 2024 & has been associated with this company since 1 year 12 days . was documented.
Mesco Pharmaceuticals Limited last Annual general meeting of members was held on 29 Sep 2021 as per latest MCA records. was recorded as a recent event.
Progress on Mesco Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Uttarakhand. was documented.
Dhruv Singh was appointed as a CEO was appointed as a CEO on 31 Jul 2020 & has been associated with this company since 5 years 4 months . was recorded as a recent event.
The activity Dhruv Dushyant Kumar Singh was appointed as a Director was appointed as a Director on 31 Jul 2020 & has been associated with this company since 5 years 4 months . was completed.
Progress on Hawa Singh Chahar was appointed as a Director was appointed as a Director on 21 Jun 2019 & has been associated with this company since 6 years 5 months . was documented.
The CIN of Mesco Pharmaceuticals Limited is L24111UR1986PLC015895.
Mesco Pharmaceuticals Limited is headquartered at Upper Kesalton Tallital Nanital, Nanital, Uttarakhand, 263001.
Mesco Pharmaceuticals Limited was incorporated on 12 August 1986.
The current directors of Mesco Pharmaceuticals Limited are
The primary industry of Mesco Pharmaceuticals Limited is Pharma.
Mesco Pharmaceuticals Limited is listed. It is listed on BSE: 500274.
The authorized capital of Mesco Pharmaceuticals Limited is ₹30.00 Cr, and the paid-up capital is ₹19.74 Cr.
The compliance status of Mesco Pharmaceuticals Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX